ClinicalTrials.gg

What’s New Sign In

Clinical trials in Australia

12,604 studies list at least one site in Australia. 2,189 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-11-10.

Status

Completed: 7,086
Recruiting: 1,909
Terminated: 1,395
Active, not recruiting: 1,340
Status unknown: 429
Not yet recruiting: 198

Phase

Phase 3: 4,404
Phase 2: 3,545
Phase 1: 2,766
Phase 4: 503
Early Phase 1: 60

Most studied here

Who runs them

Novartis Pharmaceuticals (431) · Hoffmann-La Roche (422) · GlaxoSmithKline (372) · AstraZeneca (342) · Pfizer (335) · Bristol-Myers Squibb (298) · Eli Lilly and Company (232) · Sanofi (216)

What changed recently

From the registry's own updates since Oct 11, 2026.

Started recruiting46

A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With AutismNov 10, 2026NCT07284745
Study Comparing BGB-B2033 With Sorafenib or Lenvatinib in Advanced Hepatocellular CarcinomaNov 10, 2026NCT07836530
A First-in-Human Study of ZE66-0205 in Healthy VolunteersNov 9, 2026NCT07735728
A Study to Investigate How Well an Intracolonic Formulation of Two Monoclonal Antibodies is Tolerated in Healthy Participants and the Ability for the Antibodies to be Taken up by the Body Via the ColonNov 9, 2026NCT07788807
Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's DiseaseNov 6, 2026NCT07781657

Show 41 more

A Clinical Trial of V175 and V175A in Healthy AdultsNov 6, 2026NCT07855510
A Study to Evaluate the Performance, and Usability of TruPlex HIV/HepB/Syphilis Rapid TestNov 4, 2026NCT07569913
A Study of the Safety and Efficacy of TRTL-913 in Healthy Volunteers (Part A) and in Adults With Tinnitus (Part B)Nov 4, 2026NCT07777549
A Study to Determine the Safety and Efficacy of NT-501 With M-CHFMNov 3, 2026NCT06397131
Mo-Rez in First- Line (1L) Maintenance Treatment of Non-Homologous Recombination Deficient Ovarian Cancer (Non-HRd OC) [BEHOLD-Ovarian03]Nov 3, 2026NCT07694427
Phase Ia Study of MST-931 in Healthy Adult SubjectsNov 3, 2026NCT07903493
Evaluate the Efficacy and Safety of ABP-671 in Subjects With Chronic Kidney Disease and HyperuricaemiaNov 2, 2026NCT07323095
Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial CancerOct 30, 2026NCT07578649
A Study to Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHLOct 30, 2026NCT07607925
Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia.Oct 29, 2026NCT07518329
A Study of HL40626S Tablets in Healthy AdultsOct 29, 2026NCT07736586
Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)Oct 28, 2026NCT04886804
PRA-216 COPD Safety and Biomarker StudyOct 28, 2026NCT07730281
PRA-216 Atopic Dermatitis Safety and Efficacy StudyOct 28, 2026NCT07810777
A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia AOct 28, 2026NCT07830732
Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)Oct 27, 2026NCT06295731
A Clinical Trial of MK-8644 in Healthy Participants and Participants With Psoriasis (MK-8644-001)Oct 27, 2026NCT07850310
INTERACT4 Expansion - Validation StudyOct 26, 2026NCT07231315
mRNA Vaccine Targeting Epstein-Barr Virus (EBV) in Healthy Young AdultsOct 26, 2026NCT07557602
Global, Multicenter Study of AMT-116 Versus Investigator's Choice in Participants With Advanced or Metastatic Non-squamous EGFR-Wildtype Non-Small Cell Lung Cancer (NSCLC) With Progression on or After Platinum-Based Chemotherapy and Anti-PD-1/PD-L1 ImmunotherapyOct 26, 2026NCT07718737
A Study of SA030 Injection in Overweight or Obese ParticipantsOct 23, 2026NCT07479862
A Single Ascending Dose and Multiple Ascending Doses Study of SYH2082 Injection in Healthy ParticipantsOct 23, 2026NCT07532655
A Study to Test CRT-402 in Refractory Autoimmune DiseaseOct 22, 2026NCT07778446
Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe AsthmaOct 21, 2026NCT07120503
Clinical Evaluation of a Novel Trifocal IOLOct 21, 2026NCT07587138
ACT-GLOBAL IA Thrombolysis(ACT-REACT-004)Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632Oct 21, 2026NCT07687056
A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).Oct 21, 2026NCT07735637
A Study of Single and Multiple Subcutaneous or Intravenous Doses of ADX-001 in Healthy Adults to Assess Safety, Effects, and Immune ResponseOct 21, 2026NCT07876076
A Phase 1b/2a, Open-label Single Ascending Doses and Multiple Ascending Doses Study in Participants With Pi*ZZ AATDOct 19, 2026NCT06405633
A Study of AN4035 in Advanced Cancers With RAS Mutations and High CEACAM5 ExpressionOct 16, 2026NCT07686445
A Study to Evaluate ATX-898 in Participants With Advanced Solid TumorsOct 16, 2026NCT07767474
Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian CancerOct 16, 2026NCT07816666
SumMET: Study of [225Ac]Ac-FL-261 in Participants With Solid Tumors Overexpressing c-METOct 16, 2026NCT07873450
A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)Oct 15, 2026NCT07159763
A Phase 1 Study of DEM301 in Participants With Metastatic Colorectal CancerOct 15, 2026NCT07805369
A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or ObesityOct 15, 2026NCT07845500
Primary Radiotherapy In MEtastatic Lung CancerOct 14, 2026NCT07135882
A Study to Test How Well Different Doses of BI 4060107 Are Tolerated by People With Advanced Cancer (Solid Tumours)Oct 14, 2026NCT07827144
A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor ResectionOct 13, 2026NCT07128199
A Trial in Healthy Adult Participants and Adults With Autoimmune Diseases to Test How HBM7020 is Tolerated and How it Behaves in the BodyOct 13, 2026NCT07649265
A Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small Cell Lung Cancer (Dareon®-Rosetta35)Oct 13, 2026NCT07843940

First site in Australia57

Study Comparing BGB-B2033 With Sorafenib or Lenvatinib in Advanced Hepatocellular CarcinomaNov 10, 2026NCT07836530
Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial HypertrophyNov 9, 2026NCT06941870
Clinical Trial in Patients With Barth Syndrome- 4TAZPowerNov 9, 2026NCT07531251
A Study to Investigate How Well an Intracolonic Formulation of Two Monoclonal Antibodies is Tolerated in Healthy Participants and the Ability for the Antibodies to be Taken up by the Body Via the ColonNov 9, 2026NCT07788807
A Repeat Dose Study of the Dexmedetomidine Transdermal System in Healthy SubjectsNov 9, 2026NCT07818330

Show 45 more

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1Nov 6, 2026NCT07563881
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal SeizuresNov 6, 2026NCT07594119
Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's DiseaseNov 6, 2026NCT07781657
A Clinical Trial of V175 and V175A in Healthy AdultsNov 6, 2026NCT07855510
To Evaluate the Effects of Cevostamab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus NephritisNov 5, 2026NCT07629583
A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or ObesityNov 5, 2026NCT07845500
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell TherapyNov 4, 2026NCT07188558
Study of EVO756 in Adults With MigraineNov 4, 2026NCT07616128
A Study of the Safety and Efficacy of TRTL-913 in Healthy Volunteers (Part A) and in Adults With Tinnitus (Part B)Nov 4, 2026NCT07777549
A Study of Brepocitinib in Adults With Cutaneous SarcoidosisNov 3, 2026NCT06978725
A Study of Orelabrutinib in Patients With Primary Progressive Multiple SclerosisNov 3, 2026NCT07067463
A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast CancerNov 3, 2026NCT07524855
A Study of Ramantamig Plus Daratumumab Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) or Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With NDMM For Whom Stem Cell Transplant is Not PlannedNov 3, 2026NCT07665450
Mo-Rez in First- Line (1L) Maintenance Treatment of Non-Homologous Recombination Deficient Ovarian Cancer (Non-HRd OC) [BEHOLD-Ovarian03]Nov 3, 2026NCT07694427
Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1)Nov 3, 2026NCT07702032
A Study of JNJ-101556143 in Participants With Metastatic Prostate CancerNov 3, 2026NCT07832292
Phase Ia Study of MST-931 in Healthy Adult SubjectsNov 3, 2026NCT07903493
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)Nov 2, 2026NCT06966401
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion MutationsOct 30, 2026NCT06043817
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003).Oct 30, 2026NCT06843447
A Study to Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHLOct 30, 2026NCT07607925
PRA-216 COPD Safety and Biomarker StudyOct 28, 2026NCT07730281
SPN-817 Open-Label Extension Study in Adults With Focal Onset SeizuresOct 27, 2026NCT07141329
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple SclerosisOct 27, 2026NCT07299019
A Clinical Trial of MK-8644 in Healthy Participants and Participants With Psoriasis (MK-8644-001)Oct 27, 2026NCT07850310
A Study to Determine the Safety and Efficacy of NT-501 With M-CHFMOct 26, 2026NCT06397131
A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)Oct 26, 2026NCT07244341
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative ColitisOct 23, 2026NCT07184996
A Single Ascending Dose and Multiple Ascending Doses Study of SYH2082 Injection in Healthy ParticipantsOct 23, 2026NCT07532655
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary DiseaseOct 22, 2026NCT07363694
Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung CancerOct 21, 2026NCT05168566
Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)Oct 21, 2026NCT06891443
Clinical Evaluation of a Novel Trifocal IOLOct 21, 2026NCT07587138
A Study of Single and Multiple Subcutaneous or Intravenous Doses of ADX-001 in Healthy Adults to Assess Safety, Effects, and Immune ResponseOct 21, 2026NCT07876076
Danon Disease Natural History StudyOct 19, 2026NCT06214507
Pharmacokinetic Characteristics, Safety, and Immunogenicity of HLX29 Compared With HLX11Oct 19, 2026NCT07776132
Breathing-Maneuver-Induced Myocardial Oxygenation Reserve Validated by FFR (B-MORE)Oct 16, 2026NCT04126148
PulseSelect™ PFA Global RegistryOct 16, 2026NCT06393920
EMBodied psychOsocial Impacts of Weight Stigma During Pregnancy (EMBODY): A Prospective Cohort StudyOct 16, 2026NCT06531694
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative ColitisOct 16, 2026NCT07185009
A Study to Evaluate ATX-898 in Participants With Advanced Solid TumorsOct 16, 2026NCT07767474
SumMET: Study of [225Ac]Ac-FL-261 in Participants With Solid Tumors Overexpressing c-METOct 16, 2026NCT07873450
Western Sydney Kidney Injury Biopsy StudyOct 15, 2026NCT06254677
A Phase 1 Study of DEM301 in Participants With Metastatic Colorectal CancerOct 15, 2026NCT07805369
GEnomic Medicine in Kidney Transplantation StudyOct 14, 2026NCT06365411

and 7 more not listed

Results posted33

A Study of Lebrikizumab (RO5490255) in Participants With Severe Oral Corticosteroids (OCS) Dependent AsthmaNov 10, 2026NCT01987492
Pegcetacoplan Long Term Safety and Efficacy Extension StudyNov 10, 2026NCT03531255
Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPCNov 10, 2026NCT03792841
Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple MyelomaNov 9, 2026NCT04091126
A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung CancerNov 9, 2026NCT04294810

Show 28 more

A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital HerpesNov 9, 2026NCT05298254
Pilot Study of Nivolumab in Pediatric Patients With Hypermutant CancersNov 5, 2026NCT02992964
A Study of JNJ-63733657 in Participants With Early Alzheimer's DiseaseNov 5, 2026NCT04619420
A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (HS)Nov 5, 2026NCT05620836
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With BiktarvyNov 5, 2026NCT06333808
Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell TransplantNov 4, 2026NCT04543591
Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy PatientsNov 4, 2026NCT04578834
Lead EvaluAtion for Defibrillation and Reliability (LEADR) / Lead Evaluation for Defibrillation and Reliability in Left Bundle Branch Area Pacing (LEADR LBBAP)Nov 4, 2026NCT04863664
Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)Nov 4, 2026NCT04968184
A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)Nov 3, 2026NCT04628494
An Evaluation of the Safety and Efficacy of Methylone for the Treatment of PTSDOct 30, 2026NCT06215261
ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKEOct 29, 2026NCT05746559
A Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical StudyOct 28, 2026NCT02875548
An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMDOct 28, 2026NCT04770545
Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With CirrhosisOct 28, 2026NCT05297448
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary DiseaseOct 28, 2026NCT05595642
Study of AMG 256 in Adult Subjects With Advanced Solid TumorsOct 23, 2026NCT04362748
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522)Oct 22, 2026NCT03036488
Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCLOct 21, 2026NCT04404283
A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Patients With Geographic AtrophyOct 21, 2026NCT04656561
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen (ARTISTRY-1)Oct 21, 2026NCT05502341
A Study of Rusfertide in Adults With Polycythemia Vera (PV)Oct 19, 2026NCT05210790
A Study to Investigate Natural Killer Cell Engager (SAR443579) With Different Agents in Participants With Hematological MalignanciesOct 19, 2026NCT06508489
A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary DiseaseOct 16, 2026NCT05037929
Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary FibrosisOct 15, 2026NCT05255991
Evaluation of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in Cystic Fibrosis (CF) Participants 12 to Less Than 24 Months of AgeOct 15, 2026NCT05882357
A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver CancerOct 14, 2026NCT05337137
Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or BladderOct 14, 2026NCT05512377

Stopped18

A Study of Lebrikizumab (RO5490255) in Participants With Severe Oral Corticosteroids (OCS) Dependent AsthmaTerminatedNov 10, 2026NCT01987492
A Repeat Dose Study of the Dexmedetomidine Transdermal System in Healthy SubjectsTerminatedNov 9, 2026NCT07818330
Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung CancerTerminatedNov 6, 2026NCT05132075
Long-term Extension of GTX-102 in Angelman SyndromeTerminatedNov 3, 2026NCT06415344
Pidnarulex and Talazoparib in Patients With Metastatic Castration Resistant Prostate CancerTerminatedNov 2, 2026NCT05425862

Show 13 more

A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489TerminatedNov 2, 2026NCT07073820
An Open-label Extension Safety Study of MELAS Patients Who Completed TIS6463-203 (PRIZM)TerminatedOct 30, 2026NCT06961344
Phase Ib Trial of 177Lu-PSMA-I&T Therapy in Combination With Olaparib and Pembrolizumab in Patients With Metastatic Castration Resistant Prostate CancerWithdrawnOct 30, 2026NCT07090369
A Study of PBFT02 in Participants With FTD and Mutations in the Granulin Precursor (GRN) or C9ORF72 GenesTerminatedOct 29, 2026NCT04747431
A Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical StudyTerminatedOct 28, 2026NCT02875548
A Study of MORAb-202 Versus Investigator's Choice Chemotherapy in Female Participants With Platinum-resistant High-grade Serous (HGS) Ovarian, Primary Peritoneal, or Fallopian Tube CancerTerminatedOct 28, 2026NCT05613088
A Study of CYP-001 in Combination With Corticosteroids in Adults With High-risk aGvHDTerminatedOct 22, 2026NCT05643638
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative ColitisTerminatedOct 21, 2026NCT06867094
A Study to Evaluate INCB099280 in Participants With Advanced Cutaneous Squamous Cell CarcinomaTerminatedOct 20, 2026NCT05888844
Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid TumorsTerminatedOct 19, 2026NCT05800964
Safety and Efficacy Study of PF-06835375 in Primary Immune ThrombocytopeniaTerminatedOct 16, 2026NCT05070845
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)SuspendedOct 13, 2026NCT05099003
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.TerminatedOct 13, 2026NCT06637631

Newly registered38

Continuation Study With Oral MC-1 for Treatment of Patients With PNPO-DeficiencyNov 10, 2026NCT07928388
A Study of BI 4015092, Alone or in Combination With Other Cancer Treatment, in Patients With Advanced Cancer That Has a KRAS G12D MutationNov 9, 2026NCT07926334
Phase 1/2 Study of DS010 in Advanced Cancer Patients With CachexiaNov 6, 2026NCT07921576
Study Designed to Evaluate the Safety, Tolerability, and PK of RAP-219 Formulated as an Long Acting Injectable.Nov 6, 2026NCT07923097
A Prospective, Open-label, Randomized, Multicenter Phase-III Trial to Evaluate the Efficacy of Pirtobrutinib and Epcoritamab Compared With R-(Mini)-CHOP for Treatment of Patients With DLBCL-type Richter TransformationNov 5, 2026NCT07917780

Show 33 more

A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and ObesityNov 5, 2026NCT07919405
Safety and Biodistribution of [68Ga]Ga DOTA-5G in Subjects With Metastatic Breast Cancer (BC)Nov 4, 2026NCT07915297
Perceptions and Acceptance of Grafting of Cryopreserved Testicular TissueNov 4, 2026NCT07915375
Specific and Novel Approaches to Care of Inflammatory Bowel Disease During Pregnancy: the PREGO StudyNov 4, 2026NCT07916727
Comparison of VxWave and Standard Ultrasound Measurements of Blood Vessels in the ArmNov 4, 2026NCT07916857
Zilovertamab Vedotin and Lenalidomide (ZiVLen) Therapy for Relapsed/Refractory Peripheral T-Cell LymphomaNov 3, 2026NCT07913594
Biomarker-guided RAdiation-deferring Treatment in Younger GBM Patients - Pilot StudyOct 30, 2026NCT07908147
Phase Ia Study of MST-931 in Healthy Adult SubjectsOct 29, 2026NCT07903493
Effects of Smartphone Use and Television Viewing on Standardized BP Measurement: The SCREENS-BP StudyOct 29, 2026NCT07903779
A Study of NOR-101 in Healthy Adults and Adults With Moderate-to-Severe Atopic DermatitisOct 29, 2026NCT07904689
A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of CBT-248 in Healthy Adult ParticipantsOct 29, 2026NCT07905053
Study of HXN-1013 in Healthy Participants and Participants With Mild-to-Moderate AsthmaOct 28, 2026NCT07900568
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular RiskOct 28, 2026NCT07900633
Study of CTX001 in Adults With Anemia Due to Non-Dialysis-Dependent Chronic Kidney DiseaseOct 28, 2026NCT07901933
A Trial of Adjunctive Fludrocortisone (50mcg, 100mcg or Placebo) in Critically Ill Patients With Septic Shock Receiving Hydrocortisone, Evaluating Survival and Functional Recovery and the Influence of Transcriptomic ResponseOct 27, 2026NCT07898462
EDIT-401 in Adults Who Require Additional Lowering of Low-Density Lipoprotein Cholesterol (LDL-C)Oct 26, 2026NCT07894887
Phase 2 Study of Oral Epetraborole in Adults With Polycythemia VeraOct 23, 2026NCT07891533
Clinical Trial to Assess the Safety, Tolerability, Reactogenicity, and Immunogenicity of a 10 Valent Human Papillomavirus Virus (10vHPV) VaccineOct 22, 2026NCT07888686
A Study to Evaluate a Single Dose of IBIO-610 in Participant With Obesity.Oct 22, 2026NCT07890870
Safety and Tolerability of AT-0174 in Adults With Advanced Solid TumorsOct 21, 2026NCT07885267
Artificial Intelligence for Brain MRI Analysis in EpilepsyOct 19, 2026NCT07881185
Semaglutide Health Outcomes and Patient Adherence in AustraliaOct 19, 2026NCT07881770
To Evaluate the Safety and Efficacy of Hemay5394 in Patients With Mild to Moderate Atopic DermatitisOct 16, 2026NCT07877155
An Online Tailored Cognitive Therapy-Based Intervention for Depression in Multiple Sclerosis: ACTION-MS OnlineOct 15, 2026NCT07875309
A Study to Test New Investigational Drugs (LCFA-01and LC103) for Bacterial Vaginosis (BV) TreatmentOct 15, 2026NCT07875673
A Study of Single and Multiple Subcutaneous or Intravenous Doses of ADX-001 in Healthy Adults to Assess Safety, Effects, and Immune ResponseOct 15, 2026NCT07876076
DDI Study of ECC0509 With Metformin, Midazolam, and CaffeineOct 14, 2026NCT07873229
SumMET: Study of [225Ac]Ac-FL-261 in Participants With Solid Tumors Overexpressing c-METOct 14, 2026NCT07873450
A Trial of RLX-2508-102 in Healthy VolunteersOct 14, 2026NCT07873671
Prospective Study on Antimicrobial RESIstance in Chronic Pulmonary DiseasEOct 14, 2026NCT07874139
First-in-human Trial of RBD2080 in Healthy ParticipantsOct 13, 2026NCT07869940
Healthcare and Community Service Utilisation in Older Survivors of Critical IllnessOct 13, 2026NCT07870343
A Study to Assess The Safety and Tolerability of Pumitamig-Based Therapy Administered Before Surgery in Participants With Early-Stage Non-Small Cell Lung Cancer (ROSETTA Lung-220)Oct 13, 2026NCT07871214

Studies

Recruiting first, then most recently updated. Showing 50 of 12,604 — search for more.